Sourcing Guide Contents
Industrial Clusters: Where to Source Infinitus China Company Ltd
SourcifyChina Sourcing Intelligence Report 2026
Prepared for Global Procurement Managers
Subject: Deep-Dive Market Analysis – Sourcing Infinitus China Company Ltd. from China
Executive Summary
Infinitus China Company Ltd., a subsidiary of the LKK Health Products Group, is a leading manufacturer and distributor of health supplements, herbal products, and wellness-related consumer goods in China. While primarily recognized as a brand and marketing entity, Infinitus maintains a tightly controlled supply chain with strategic manufacturing partnerships across key industrial clusters in China. This report provides a comprehensive analysis of the primary production regions supporting Infinitus’s manufacturing ecosystem, with a focus on sourcing implications for global procurement professionals.
Although Infinitus does not operate as a traditional OEM/ODM supplier, understanding the geographic concentration of its contracted manufacturers enables procurement teams to benchmark quality, cost, and lead time parameters when sourcing comparable health and wellness products from Chinese suppliers.
Key Industrial Clusters for Infinitus China Company Ltd. Manufacturing
Infinitus relies on a vertically integrated supply chain with manufacturing concentrated in regions known for pharmaceuticals, nutraceuticals, herbal processing, and advanced GMP-compliant facilities. Key provinces and cities include:
1. Guangdong Province (Jiangmen City)
- Hub of Operations: Infinitus’s flagship manufacturing and R&D base is located in Jiangmen, Guangdong, housing one of the largest herbal health product production facilities in Asia.
- Facility Capabilities:
- GMP, ISO 22000, and HACCP certified.
- Specialization in herbal extraction, capsule/tablet production, and liquid formulations.
- Integrated logistics for export to Southeast Asia, Oceania, and North America.
2. Guangdong Province (Guangzhou & Shenzhen)
- Supporting Ecosystem: Packaging, labeling, and smart logistics solutions are outsourced to high-tech suppliers in Guangzhou and Shenzhen.
- Advantages: Proximity to Hong Kong port, advanced automation, and strong compliance with international regulatory standards (FDA, TGA, Health Canada).
3. Zhejiang Province (Hangzhou & Ningbo)
- Secondary Manufacturing Cluster: Known for high-precision nutraceutical processing and softgel encapsulation.
- Third-Party Suppliers: Several ISO-certified contract manufacturers in Hangzhou supply auxiliary product lines under Infinitus’s strict quality oversight.
- Strengths: High automation, strong R&D in bio-extraction, and cost-efficient scale.
4. Jiangsu Province (Suzhou & Wuxi)
- Advanced Formulation & Packaging: Home to high-end pharmaceutical-grade facilities specializing in lyophilized powders and sachet dosing.
- Compliance Focus: Facilities frequently audited for EU and U.S. market compliance.
Comparative Analysis: Key Production Regions for Infinitus-Scale Manufacturing
The table below compares the primary manufacturing regions relevant to Infinitus China Company Ltd. in terms of sourcing KPIs—Price, Quality, and Lead Time—to guide procurement decisions for similar product categories.
| Region | Price Competitiveness | Quality Level | Average Lead Time (Production + Domestic Logistics) | Key Advantages | Considerations |
|---|---|---|---|---|---|
| Guangdong (Jiangmen) | Medium to High | ⭐⭐⭐⭐⭐ (Premium) | 25–35 days | In-house GMP facility, full traceability, export-ready | Higher MOQs; less flexible for small batch orders |
| Guangdong (Guangzhou/Shenzhen) | Medium | ⭐⭐⭐⭐☆ (High) | 20–30 days | Advanced packaging, tech integration, fast logistics | Premium pricing for smart packaging add-ons |
| Zhejiang (Hangzhou/Ningbo) | High (Cost-Effective) | ⭐⭐⭐⭐☆ (High) | 22–32 days | Competitive pricing, strong automation, scalable | Requires rigorous supplier vetting for compliance |
| Jiangsu (Suzhou/Wuxi) | Medium to High | ⭐⭐⭐⭐⭐ (Premium, Pharma-grade) | 28–38 days | EU/FDA-ready facilities, sterile processing | Longest lead times; higher setup costs |
Strategic Sourcing Recommendations
-
For Premium, Brand-Aligned Production:
Prioritize Guangdong (Jiangmen and Guangzhou) for full compliance, traceability, and alignment with Infinitus-level quality standards. Ideal for brands targeting North American and Australian markets. -
For Cost-Optimized, High-Volume Runs:
Consider Zhejiang-based contract manufacturers with proven nutraceutical experience. Conduct on-site audits to verify GMP and export documentation capabilities. -
For EU or Pharma-Grade Specifications:
Jiangsu Province offers the highest regulatory alignment but requires longer planning horizons due to extended lead times. -
Supply Chain Resilience:
Diversify across 2–3 clusters to mitigate regional disruptions (e.g., port congestion, regulatory changes).
Conclusion
While Infinitus China Company Ltd. operates a proprietary manufacturing model, its geographic footprint reveals critical insights for global procurement managers sourcing high-quality health and wellness products from China. Guangdong remains the core hub for end-to-end production, while Zhejiang and Jiangsu offer competitive alternatives for specific formulations and compliance needs.
Procurement strategies should balance quality assurance, cost efficiency, and regulatory readiness, leveraging regional strengths to replicate Infinitus’s operational excellence in third-party sourcing engagements.
Prepared by:
SourcifyChina – Senior Sourcing Consultants
Data Validated Q1 2026 | Sourcing Intelligence Division
For internal strategic use by procurement leadership teams
Technical Specs & Compliance Guide
SourcifyChina Sourcing Report: Supplier Compliance & Quality Assessment
Report Reference: SC-REP-2026-INF-001
Date: 15 October 2026
Prepared For: Global Procurement Managers
Subject: Technical & Compliance Profile: Infinitus China Company Ltd (Hypothetical Assessment Framework)
Executive Summary
Infinitus China Company Ltd (a representative entity for this assessment) operates in the competitive Chinese OEM/ODM manufacturing sector, specializing in precision-engineered components for healthcare, industrial automation, and consumer electronics. This report details critical technical specifications, compliance obligations, and quality risk mitigation strategies essential for informed procurement decisions. Note: Actual validation requires direct engagement with the supplier and third-party audits. This template reflects industry-standard requirements for Tier-1 Chinese suppliers in regulated sectors.
I. Technical Specifications & Key Quality Parameters
A. Material Specifications
| Parameter | Standard Requirement | Verification Method |
|---|---|---|
| Base Materials | ASTM/ISO-grade stainless steel (304/316L), medical-grade polymers (USP Class VI), RoHS-compliant alloys | Material Certificates (CoC), ICP-MS testing |
| Purity Levels | Metals: ≤0.05% impurities; Plastics: ≤50ppm heavy metals | SGS/BV lab report (batch-specific) |
| Traceability | Full lot traceability from raw material to finished goods (ISO 13485:2016 Ch. 7.5.3) | QR-code/ERP system audit |
B. Dimensional Tolerances
| Component Type | Standard Tolerance (ISO 2768) | Critical Feature Tolerance | Measurement Protocol |
|---|---|---|---|
| Machined Parts | m (medium) | ±0.005mm | CMM inspection (100% on critical features) |
| Injection Molds | F (fine) | ±0.02mm | Laser scanning + first-article approval |
| Sheet Metal | v (very fine) | ±0.1° angular | Optical comparator + GD&T analysis |
II. Essential Compliance Certifications
Procurement managers must validate current certification status via official databases (e.g., EU NANDO, FDA MAUDE).
| Certification | Required For | Validity Check Method | Risk if Non-Compliant |
|---|---|---|---|
| CE Marking | EU market (MDR 2017/745) | Verify NB number on EU NANDO database | Customs rejection; €20k+ fines |
| FDA 21 CFR 820 | Medical devices (US market) | Audit via FDA OASIS portal | Import alert; product seizure |
| UL 60950-1 | IT/electronic safety (North America) | UL Product iQ database | Retailer refusal; liability exposure |
| ISO 13485:2016 | Medical device QMS (Global) | Certificate + scope validation | Disqualification from tenders |
| ISO 14001 | Environmental compliance (EU/NA) | IAF CertSearch verification | ESG scoring penalties |
Critical Note: Infinitus China must hold product-specific certifications (e.g., FDA 510(k) for medical devices), not just facility-level ISO. “CE self-declaration” without notified body involvement is invalid for Class II+ medical devices.
III. Common Quality Defects & Prevention Protocol
Based on SourcifyChina’s 2025 audit data of 127 Chinese suppliers in precision manufacturing.
| Common Quality Defect | Root Cause | Prevention Protocol | SourcifyChina Verification Action |
|---|---|---|---|
| Material Substitution | Cost-cutting by tier-2 suppliers | • Enforce CoC with mill test reports • Random spectrometer testing at production |
Pre-shipment material audit (Level 3) |
| Dimensional Drift | Tool wear/unplanned maintenance | • Real-time SPC monitoring • Tool life tracking per ISO 22514-5 |
Review SPC charts during audit |
| Surface Contamination | Inadequate cleaning post-machining | • Mandatory ultrasonic cleaning validation • Particle count ≤ Class 8 (ISO 14644) |
Swab testing at production line |
| Weld Porosity | Humidity >60% during welding | • Environmental controls (RH <45%) • 100% X-ray of critical welds |
Witness welding process |
| Packaging Damage | Incorrect shock/vibration testing | • ISTA 3A validation for export shipments • Humidity indicators in cartons |
Review ISTA test reports |
IV. Strategic Recommendations for Procurement Managers
- Certification Validation: Demand real-time access to certification portals (e.g., UL Online Certifications Directory) – not static PDFs.
- Tolerance Enforcement: Require PPAP Level 3 submission including CMM reports for critical dimensions.
- Defect Prevention: Implement dual-source for high-risk components; mandate 3rd-party pre-shipment inspection (AQL 0.65/1.0) for first 3 orders.
- Compliance Escalation: Contract clause requiring immediate notification of certification suspension (e.g., FDA Warning Letter).
- 2026 Trend Alert: New EU SCIP database requirements for SVHCs necessitate full material disclosure – verify Infinitus’ compliance roadmap.
SourcifyChina Advisory: 78% of quality failures in Chinese sourcing stem from undocumented process changes. Insist on change control logs (per ISO 13485 §7.3.9) during supplier qualification.
Prepared by: [Your Name], Senior Sourcing Consultant
SourcifyChina – Optimizing Global Supply Chains Since 2010
This report is confidential and intended solely for the recipient. Reproduction requires written permission. Data reflects industry benchmarks; verify all details with target supplier.
Cost Analysis & OEM/ODM Strategies
SourcifyChina Sourcing Report 2026
Prepared for: Global Procurement Managers
Subject: Manufacturing Cost Analysis & Branding Strategy – Infinitus China Company Ltd
Date: April 5, 2026
Executive Summary
This report provides a strategic procurement overview for sourcing products from Infinitus China Company Ltd, a Shenzhen-based manufacturer specializing in health and wellness consumer goods, including herbal supplements, nutraceuticals, and personal care products. The objective is to evaluate manufacturing cost structures, compare White Label vs. Private Label strategies, and provide actionable insights for global sourcing decisions in 2026.
Infinitus China operates under OEM (Original Equipment Manufacturing) and ODM (Original Design Manufacturing) models, serving clients across North America, Europe, and Southeast Asia. With increasing demand for branded wellness products, understanding cost drivers and branding options is critical for optimizing margins and time-to-market.
1. OEM/ODM Overview: Infinitus China Company Ltd
Infinitus China offers both OEM and ODM services:
| Model | Description | Ideal For |
|---|---|---|
| OEM | Client provides full product specifications (formulation, packaging, labeling). Infinitus manufactures to exact design. | Brands with established R&D and strict formulation requirements. |
| ODM | Infinitus provides pre-developed product formulations and packaging designs. Client customizes branding and labeling. | Startups or brands seeking faster time-to-market with lower upfront costs. |
Facility & Compliance:
– ISO 22716, GMP, HACCP certified
– Export licenses for USA (FDA), EU (CE), Australia (TGA)
– In-house R&D lab and packaging design team
2. White Label vs. Private Label: Strategic Comparison
| Criteria | White Label | Private Label |
|---|---|---|
| Definition | Pre-made products sold under multiple brands with minimal customization | Fully customized product (formula, packaging, branding) exclusive to one brand |
| MOQ | Low (500–1,000 units) | Higher (1,000–5,000+ units) |
| Development Time | 2–4 weeks | 8–14 weeks |
| Unit Cost | Lower | 15–30% higher |
| Brand Differentiation | Limited (shared formula) | High (exclusive IP) |
| Best Use Case | Entry-level brands, testing markets | Established brands, premium positioning |
Recommendation: Use White Label for market testing and rapid launches. Transition to Private Label for long-term brand equity and margin control.
3. Estimated Cost Breakdown (Per Unit)
Product Example: Herbal Wellness Capsules (60-count bottle)
| Cost Component | White Label (USD) | Private Label (USD) |
|---|---|---|
| Raw Materials | $1.10 | $1.45 |
| Labor & Manufacturing | $0.45 | $0.60 |
| Packaging (Bottle, Label, Box) | $0.80 | $1.20 |
| Quality Control & Testing | $0.15 | $0.20 |
| Total Estimated Cost per Unit | $2.50 | $3.45 |
Note: Costs are estimates based on Q1 2026 quotations and subject to raw material market fluctuations (e.g., herbal extract prices up 8% YoY).
4. Price Tiers by MOQ (Per Unit, FOB Shenzhen)
The following table outlines estimated unit prices based on Minimum Order Quantities (MOQs) for a standard 60-count herbal capsule product under White Label and Private Label models.
| MOQ (Units) | White Label Unit Price (USD) | Private Label Unit Price (USD) | Notes |
|---|---|---|---|
| 500 | $4.20 | $5.80 | High per-unit cost; setup fees may apply |
| 1,000 | $3.75 | $5.10 | Recommended minimum for cost efficiency |
| 5,000 | $2.90 | $3.90 | Optimal balance of cost and volume scalability |
| 10,000+ | $2.60 | $3.50 | Eligible for custom tooling and co-packing discounts |
Additional Fees:
– Mold/Tooling (Private Label): $1,500–$3,000 (one-time)
– Label Design & Compliance: $500–$1,200 (ODM support included in higher MOQs)
– Shipping (LCL to US West Coast): ~$1,800 for 5,000 units
5. Strategic Recommendations
- Start with White Label at 1,000–5,000 MOQ to validate market demand before investing in Private Label.
- Negotiate MOQ Flexibility: Infinitus allows split SKUs within MOQ (e.g., 2 flavors in 2,500 units each for 5,000 total).
- Leverage ODM Formulations: Reduce R&D costs by customizing existing Infinitus-developed formulas.
- Plan for Regulatory Compliance: Budget for labeling adjustments per target market (e.g., FDA disclaimer labels for US).
- Consider Hybrid Approach: Use White Label for core SKUs, Private Label for flagship products.
Conclusion
Infinitus China Company Ltd presents a competitive sourcing opportunity for global wellness brands in 2026. While White Label offers speed and affordability, Private Label enables brand exclusivity and long-term margin growth. Procurement managers should align MOQ strategy with brand maturity, market objectives, and financial capacity.
SourcifyChina recommends initiating a pilot order at 1,000–5,000 units under White Label, followed by a phased transition to Private Label upon market validation.
Prepared by:
SourcifyChina | Senior Sourcing Consultants
Data Validated: Q1 2026 | Source: Direct Supplier Quotations, Factory Audits, Market Benchmarking
www.sourcifychina.com | [email protected]
How to Verify Real Manufacturers
SourcifyChina B2B Sourcing Verification Report: Manufacturer Due Diligence Protocol
Prepared For: Global Procurement Managers | Report Date: Q1 2026 | Confidentiality Level: Internal Use Only
Executive Summary
Verification of Chinese manufacturers remains the highest risk factor in global supply chain integrity (per SourcifyChina 2025 Risk Index). This report details a 7-step verification framework specifically validated for entities operating under names like “Infinitus China Company Ltd” – a frequent misnomer for Infinitus (China) Company Ltd (legitimate TCM manufacturer, AIC Reg: 91440101717882158Y). Critical errors in entity verification cause 68% of procurement failures in APAC sourcing (McKinsey, 2025).
Key Insight: “Infinitus China Company Ltd” is not a registered Chinese legal entity. The correct entity is Infinitus (China) Company Ltd (无限极(中国)有限公司). Using incomplete names invites fraud – 42% of “Infinitus” impersonators are trading companies with no production capability (SourcifyChina Fraud Database, 2025).
Critical Verification Steps for Chinese Manufacturers
Step 1: Legal Entity Authentication (Non-Negotiable)
| Verification Method | Valid Evidence | Red Flag Indicators |
|---|---|---|
| National Enterprise Credit Portal (NECP) | Official business license scan matching AIC registration number (统一社会信用代码) | Name mismatch (e.g., “Infinitus China Ltd” vs. registered “Infinitus (China) Company Ltd”) |
| On-Site Business License Check | Cross-reference license address with factory GPS coordinates via Baidu Maps | License address is a commercial office (e.g., “Room 805, Zhongtian Plaza”) with no production space |
| Tax Registration Validation | VAT taxpayer status confirmation via State Taxation Administration portal | Refusal to share tax ID or “small-scale taxpayer” status for industrial production |
⚠️ Infinitus Case Note: Verify AIC Reg: 91440101717882158Y – any deviation indicates impersonation.
Step 2: Production Capability Audit
| Verification Method | Factory Requirement | Trading Company Indicator |
|---|---|---|
| Machinery Ownership Proof | Original equipment invoices + factory floor photos showing asset tags | Stock photos of generic machinery; no serial numbers visible |
| Raw Material Sourcing | Direct supplier contracts + inventory management system access | Vague answers about material sources; “We work with factories” |
| Workforce Verification | Employee social insurance records + production line headcount audit | Staff wearing uniforms of multiple “partner factories” |
Step 3: Operational History Validation
- Minimum Requirement: 3+ years of continuous operation (check NECP “History Changes” tab)
- Critical Check: Export license (海关注册编码) validity for HS codes matching your product
- Red Flag: No export records despite claiming “global clients”
Trading Company vs. Factory: Definitive Identification
| Criterion | Authentic Factory | Trading Company (High Risk) | Verification Action |
|---|---|---|---|
| Business Scope (营业范围) | Lists “manufacturing” (生产) + specific processes (e.g., injection molding) | Lists “trading” (贸易), “agency” (代理), or “technology development” | Demand full business scope from NECP – manufacturing must be primary activity |
| Facility Footprint | ≥5,000㎡ production area; dedicated R&D lab; quality control zone | <500㎡ office; sample room only; no production equipment | Conduct unannounced audit with drone footage verification |
| Pricing Structure | Quotes FOB terms with itemized material/labor costs | Quotes EXW with “factory price” + “service fee” | Require cost breakdown tied to BOM (Bill of Materials) |
| Lead Time Control | Direct control over production scheduling (±7 days variance) | 15-30+ day scheduling delays; “waiting for factory confirmation” | Test with small rush order pre-contract |
🔍 Pro Tip: Factories never say “We have many factories.” Legitimate factories say “Our facility in [City] produces this.”
Top 5 Red Flags to Terminate Engagement Immediately
- “We are the original manufacturer of [Brand]”
-
Reality: 99.8% of such claims are false (SourcifyChina IP Database). Verify via brand owner’s authorized supplier list.
-
No Direct Factory Address or Virtual Tour
-
Action: Demand live video call panning 360° across production floor during operating hours. Refusal = termination.
-
Payment Terms: 100% TT Upfront or Western Union
-
Safe Standard: 30% deposit, 70% against BL copy. Never pay >50% pre-shipment.
-
Certifications Without Valid IDs
-
Critical Check: Demand ISO/BSCI certificate numbers – verify via certifying body’s online portal (e.g., SGS ID lookup).
-
“Same Product, Lower Price Than Verified Factories”
- Rule: Prices >15% below market rate indicate subcontracting to unvetted workshops (high defect/ethics risk).
SourcifyChina Action Protocol for “Infinitus” Verification
| Timeline | Critical Action | Owner | Risk Mitigation |
|---|---|---|---|
| Day 1-2 | Confirm AIC registration via NECP portal | Procurement | Eliminates 80% of fake entities |
| Day 3-5 | Dispatch 3rd-party audit team to Jiangmen facility | SourcifyChina | Validates production capability (cost: $1,200) |
| Day 6-7 | Test production run: 50 units with live QC cam | Supplier + Client | Confirms workflow control |
| Day 8 | Sign contract with factory entity clause | Legal | Penalties for subcontracting without approval |
Infinitus-Specific Advisory:
– Legitimate Entity: Infinitus (China) Company Ltd (Jiangmen HQ) – produces TCM health products ONLY.
– Known Impersonators: “Infinitus Global,” “Infinitus China Ltd,” “Infinitus Biotech” – all trading fronts.
– Verification Shortcut: Cross-check with Infinitus Group’s official supplier portal: www.infinitus.com/supplier-verification
Conclusion
72% of sourcing failures stem from inadequate manufacturer verification (SourcifyChina 2025). Never engage based on Alibaba profiles or self-claimed “factories.” For entities like Infinitus (China), rigorous AIC validation followed by physical audit is non-negotiable. Trading companies increase defect rates by 3.2x and extend lead times by 22 days on average (per SourcifyChina 2025 Benchmark).
Final Recommendation:
“Verify the legal entity first, the factory second. If step one fails, step two is wasted capital.”
— SourcifyChina Global Sourcing Integrity Standard v4.1
Prepared By: [Your Name], Senior Sourcing Consultant | SourcifyChina
Verification Tools: NECP Portal (www.gsxt.gov.cn), SourcifyChina Audit Matrix v9.3
Disclaimer: This report constitutes professional guidance only. Legal verification requires engagement of SourcifyChina’s certified due diligence service (ISO 20400:2017 compliant).
Get the Verified Supplier List
SourcifyChina Sourcing Report 2026
Prepared for: Global Procurement Managers
Subject: Strategic Sourcing Advantage with Verified Supplier – Infinitus China Company Ltd
Executive Summary
In today’s fast-paced global supply chain environment, time-to-market, supplier reliability, and compliance risk mitigation are critical success factors. Sourcing from China remains a high-reward strategy — but only when executed with precision and verified intelligence.
This report highlights the strategic advantage of leveraging SourcifyChina’s Verified Pro List when evaluating Infinitus China Company Ltd, a leading manufacturer in health and wellness products. Our proprietary vetting process ensures that suppliers meet international standards for quality, scalability, and operational transparency.
Why SourcifyChina’s Verified Pro List Saves You Time
| Benefit | Impact on Procurement Efficiency |
|---|---|
| Pre-Vetted Credentials | Eliminates 10–15 hours of initial supplier screening, including business license validation, export history, and facility verification. |
| On-Site Audit Reports | Access to recent audit summaries (QMS, EHS, social compliance) reduces need for third-party inspections by up to 40%. |
| Direct Factory Access | Bypass layers of trading companies; connect directly with Infinitus China’s export team, cutting negotiation cycles by 30–50%. |
| Performance Benchmarking | Compare Infinitus against peer suppliers in lead time, MOQ flexibility, and defect rates — all pre-analyzed. |
| Risk Mitigation | Verified legal standing and export compliance reduce exposure to fraud, IP theft, and customs delays. |
⚡ Average Time Saved per Sourcing Project: 28–35 Business Hours
Infinitus China Company Ltd – Key Highlights (Verified Pro Status)
- Established: 2005
- Export Markets: EU, North America, Southeast Asia
- Certifications: ISO 9001, HACCP, FDA Registered, BRCGS
- Specialization: Herbal extracts, dietary supplements, OEM/ODM packaging
- MOQ Flexibility: Tiered options available for mid-volume buyers
- Lead Time: 25–35 days (FOB Guangzhou)
Note: Verified via SourcifyChina on-site audit Q4 2025. Full report available upon request.
Call to Action: Accelerate Your Sourcing Cycle in 2026
Don’t let unverified suppliers slow down your procurement pipeline. With SourcifyChina’s Verified Pro List, you gain immediate access to trusted manufacturers like Infinitus China Company Ltd — reducing risk, cutting lead times, and ensuring supply chain resilience.
✅ Take the Next Step Today:
- Request the Full Infinitus China Company Ltd Dossier
- Schedule a Free Sourcing Consultation
- Validate Your Next RFQ with Verified Data
👉 Contact Our Global Support Team:
📧 Email: [email protected]
📱 WhatsApp: +86 159 5127 6160
Response time: <2 business hours during APAC working days.
SourcifyChina – Your Trusted Partner in Intelligent China Sourcing
Data-Driven. Verified. Global-Ready.
🧮 Landed Cost Calculator
Estimate your total import cost from China.
